Scleral Lenses Market Size was valued at USD 0.28 Billion in 2022. The Scleral Lenses Market industry is projected to grow from USD 0.30 Billion in 2023 to USD 0.50 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.80% during the forecast period (2024 - 2032). The increasing incidence of ocular disorders, supportive reimbursement policies, and the unique advantages offered by scleral lenses compared to soft lenses are expected to be significant market drivers for the Scleral Lenses Market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Rising number of eye disorders and the increasing geriatric population are driving the market growth
Market CAGR for Scleral Lenses is driven by the rising number of eye disorders and the increasing geriatric population. Scleral lenses are utilized for correcting various vision defects such as myopia, irregular cornea, ocular surface disease, refractive errors, hyperopia, astigmatism, and presbyopia. The anticipated rise in the prevalence of these conditions is expected to propel the scleral lens market in the forecast period. According to the World Health Organization, myopia has the highest prevalence in East Asian countries like Japan, South Korea, and Singapore. A 2019 article from the National Center for Biotechnology Information predicts that by 2050, myopia and high myopia are projected to impact approximately 4,949 million and 925 million people ly, respectively. The increasing instances of myopia, coupled with growing expenditure on ophthalmic products, including scleral lenses as corrective measures for refractive errors, are anticipated to fuel the growth of the scleral lenses market.
With a substantial population base, developing nations ly, including Mexico, BRIC nations (Brazil, Russia, India, China), and South Africa, present promising growth opportunities for manufacturers of contact lenses. China and India, having the highest populations, generate a significant demand for scleral lenses due to the increasing prevalence of eye defects attributed to the growing geriatric population in these regions. The geriatric population is expected to surge from 548 million in 2019 to nearly 1.3 billion by 2050, contributing to the prevalence of age-related eye diseases. Increasing awareness of eye disorders, evolving lifestyles, rising per capita spending, and market saturation in emerging economies are factors prompting market players to expand their presence in these promising markets.
As a result, it is anticipated that throughout the projection period, demand for the Scleral Lenses Market will increase due to the rising number of eye disorders and the increasing geriatric population. Thus, driving the Scleral Lenses Market revenue.
The Scleral Lenses Market segmentation, based on Type includes Corneo-Scleral Lenses and Semi-Scleral Lenses, Mini-Scleral Lenses, and Full Scleral Lenses. The Corneo-Scleral Lenses and Semi-Scleral Lenses segment dominated the market, accounting for 58% of market revenue. The market is experiencing growth due to the rising prevalence of corneal transplantation. For instance, a survey conducted by the National Center for Biotechnology Information in 2020 on 'Corneal transplantation' revealed that approximately 185,000 such procedures were conducted ly annually, with 34% occurring in the United States. Corneo-scleral lenses emerge as an innovative treatment option for individuals who have undergone corneal transplantation, offering distinct advantages. These lenses are not only beneficial for post-corneal transplant patients but also for those with severe dry eyes resulting from conditions such as Sjogren's syndrome, graft-versus-host disease (GVHD), and Stevens-Johnson syndrome. The larger diameter of corneo-scleral lenses proves more effective in addressing these challenges. Furthermore, the increased diameter contributes to a broader area of lens alignment, offering significantly improved stability on irregular corneal surfaces. This makes corneo-scleral lenses a valuable solution for various eye conditions, contributing to their growing adoption in the market.
The Scleral Lenses Market segmentation, based on Application includes Irregular Cornea, Ocular Surface Disease, Refractive Error, and Other Applications. The Irregular Cornea segment dominated the market, accounting for 58% of market revenue. Renowned for their comfort, scleral lenses do not directly touch the delicate cornea but instead arch over it, resting on the less sensitive sclera. This unique design improves stability, minimizes friction, and has become the preferred choice for individuals with irregular corneas seeking a more comfortable and effective vision correction solution.
The Scleral Lenses Market segmentation, based on Users includes Hospitals, Eye Clinics, and Other End Users. The Eye Clinics segment dominated the market, accounting for 60% of market revenue (0.16 Billion). The growth of this segment during the forecast period is further anticipated due to heightened awareness and increased accessibility to scleral products at the local level. Market players are strategically focusing on distributing their products through eyecare professionals, while eye clinics are adopting a patient-tailored approach. These factors collectively are expected to drive the growth of this market segment.
Figure 1: Scleral Lenses Market, by End-User, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The anticipated expansion of the Scleral Lenses market in North America can be attributed to several key factors. The market in the region is experiencing growth due to the increased focus on research and development, strategic partnerships, and the introduction of new products by key industry players. For Instance, in February 2021, Johnson & Johnson Vision, a division of Johnson & Johnson Services, unveiled the TECNIS Toric II 1-Piece Intraocular Lens in the United States. Additionally, Johnson & Johnson made a significant investment of approximately USD 4 billion in the acquisition of Abbott Medical Optics, encompassing ophthalmic products related to cataract surgery, laser refractive surgery, and consumer eye health. These product lines have been integrated with the ACUVUE Brand Contact Lenses business, operating collectively under the brand name Johnson & Johnson Vision (J&J Vision). This acquisition has positioned Johnson & Johnson competitively in cataract surgery, aligning with Abbott Medical Optics' expertise. Consequently, these strategic initiatives are driving market growth in the region.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: SCLERAL LENSES MARKET SHARE BY REGION 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Scleral Lenses Market accounts for the second-largest market share as In Western Europe, the number of individuals experiencing moderate to severe vision loss due to refractive disorders surpassed 8.5 million. Contrastingly, Eastern Europe exhibits the highest prevalence of eye problems across the continent. In 2020, nearly 7.5 percent of the population in this region faced near vision impairment, while 3.6 percent encountered moderate to severe vision loss, and two percent had mild vision afflictions. The growth of the scleral lenses market in Europe is influenced by the increasing awareness among eye care practitioners and patients regarding the advantages of these lenses. Educational initiatives and outreach programs conducted by eye care professionals and manufacturers contribute significantly to enhancing the understanding of how scleral lenses can effectively address specific eye conditions. Further, the German Scleral Lenses Market held the largest market share, and the UK Scleral Lenses Market was the fastest-growing market in the European region
The Asia-Pacific Scleral Lenses Market is expected to grow at the fastest CAGR from 2024 to 2032. India is anticipated to experience accelerated growth in the field of scleral lenses, driven by advancements in medical technology, government initiatives supporting eye problem treatments, and a substantial patient base. The expanding population and rising incidence of eye diseases in India are expected to contribute to the increased adoption of scleral lenses in the region. According to the National Blindness and Visual Impairment Survey conducted by the Union Ministry of Health and Family Welfare between 2015 and 2019, the prevalence of blindness in India stands at 0.36 percent, affecting approximately 6.2 million people. The survey also indicates a prevalence of 1.06 percent for moderate to severe visual impairment, impacting around 55 million individuals. Notably, the prevalence of blindness is 1.37 times higher in rural areas compared to urban areas, while moderate to severe visual impairment is 1.22 times more prevalent. Additionally, in individuals aged 50 and above, the prevalence of blindness is 1.43 percent, with 4.06 percent experiencing moderate to severe visual impairment. This increased prevalence has led to an enhanced availability of scleral lens products in India, with expectations of optimal growth in the forecast period. Moreover, China’s Scleral Lenses Market held the largest market share, and the Indian Scleral Lenses Market was the fastest-growing market in the Asia-Pacific region.
Scleral Lenses Market Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the Scleral Lenses market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Scleral Lenses industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Scleral Lenses industry to benefit clients and increase the market sector. In recent years, the Scleral Lenses industry has offered some of the most significant advantages to individuals with corneal irregularities, ocular surface diseases, and other vision-related challenges. Major players in the Scleral Lenses Market, including ABB Optical Group, Bausch Health Companies Inc., Visionary Optics, Essilor, Art Optical Contact Lens, Inc., CooperVision, BostonSight, AccuLens, Inc., Tru-Form Optics, SynergEyes, Valley Contax, Capricornia and Menicon Co., Ltd are attempting to increase market demand by investing in research and development operations.
Essilor is a company specializing in ophthalmic optics, engaged in the design, manufacturing, and marketing of a diverse array of products aimed at correcting vision, safeguarding eyes, and maintaining visual health. Their product range encompasses progressive, single vision, anti-fog, anti-reflective, polarized, sun, and photochromic lenses, along with reading glasses, lenses tailored for screen use, as well as various optical accessories such as lamps, filters, magnifiers, and electronic visual aids. The company also focuses on the development and marketing of equipment, instruments, and services intended for eyecare professionals. Among its prominent brands are Varilux, Crizal, Transitions, Eyezen, Xperio, Foster Grant, Bolon, and Costa. As an example of its performance, EssilorLuxottica reported a 13.4% decrease in sales in the Lenses and Optical Instruments segment in 2020 compared to 2019.
BostonSight is at the forefront of advancing the treatment of diseased or damaged corneas and addressing dry eyes. Since its establishment in 1992 in Needham, MA, the Center of Excellence has been instrumental in saving the sight of numerous individuals grappling with ocular surface disease and irregular corneas. The facility encompasses a clinic, research center, cutting-edge manufacturing lab, and a support center for patients and their families. The PROSE® by BostonSight represents a medical treatment employing highly customized scleral lens devices. These devices are designed to restore both visual and physiological function in patients dealing with ocular surface disease, corneal issues, injuries, or damage. For many individuals, this treatment stands as the sole option to regain vision and alleviate the suffering caused by critical and debilitating eye conditions. Expanding access to their scleral lens technology, BostonSight SCLERAL® aims to optimize scleral lens fitting, thereby enhancing satisfaction for both patients and practitioners. This ready-to-fit scleral lens option enables practitioners to promptly and effectively assist patients in achieving optimal vision and comfort.
Key companies in the Scleral Lenses Market include
Scleral Lenses Industry Developments
November 2021: In November 2021, Optimized Pupil Optics (OPO) was introduced by CooperVision Specialty EyeCare for its Onefit MED and Onefit MED+ scleral contact lenses, making them available to eye care providers (ECPs) in the United States and Canada.
October 2021: In October 2021, Bausch Health Companies Inc. released the New 28 Lens Zenlens Dx Set to address the increasing need for gas-permeable lenses in correcting vision issues related to corneal irregularities.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 0.28 Billion |
| Market Size 2023 | USD 0.30 Billion |
| Market Size 2032 | USD 0.50 Billion |
| Compound Annual Growth Rate (CAGR) | 6.80% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application, End-User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | ABB Optical Group, Bausch Health Companies Inc., Visionary Optics, Essilor, Art Optical Contact Lens, Inc., CooperVision, BostonSight, AccuLens, Inc., Tru-Form Optics, SynergEyes, Valley Contax, Capricornia and Menicon Co., Ltd |
| Key Market Opportunities | ·        Technological advancements in lens design, materials, and manufacturing processes. |
| Key Market Dynamics | ·        Increasing awareness and adoption among patients and eye care professionals. |
Frequently Asked Questions (FAQ) :
The Scleral Lenses Market size was valued at USD 0.28 Billion in 2022.
The Scleral Lenses Market is projected to grow at a CAGR of 6.80% during the forecast period, 2024-2032.
North America had the largest share of the market
The key players in the market are ABB Optical Group, Bausch Health Companies Inc., Visionary Optics, Essilor, Art Optical Contact Lens, Inc., CooperVision, BostonSight, AccuLens, Inc., Tru-Form Optics, SynergEyes, Valley Contax, Capricornia and Menicon Co., Ltd
The Corneo-Scleral Lenses and Semi-Scleral Lenses segment dominated the market in 2022.
The Eye Clinics segment had the largest share in the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
